Education
About Us
Working with TipRanks
Follow Us
ViaDerma, Inc. (VDRM)
:VDRM
VDRM Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume2.73M
Average Volume (3M)581.10K
Market Cap
$863.60K
Enterprise ValueN/A
Total Cash (Recent Filing)$1.49M
Total Debt (Recent Filing)$1.86M
Price to Earnings (P/E)―
Beta-1.15
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding1,233,713,100
10 Day Avg. Volume428,867
30 Day Avg. Volume581,103
Financial Highlights & Ratios
PEG Ratio0.31
Price to Book (P/B)-145.25
Price to Sales (P/S)0.00
P/FCF Ratio-41.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
VDRM FAQ
What was ViaDerma, Inc.’s price range in the past 12 months?
ViaDerma, Inc. lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is ViaDerma, Inc.’s market cap?
ViaDerma, Inc.’s market cap is $863.60K.
When is ViaDerma, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ViaDerma, Inc.’s earnings last quarter?
ViaDerma, Inc. released its earnings results on Oct 03, 2024. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is ViaDerma, Inc. overvalued?
According to Wall Street analysts ViaDerma, Inc.’s price is currently Overvalued.
Does ViaDerma, Inc. pay dividends?
ViaDerma, Inc. does not currently pay dividends.
What is ViaDerma, Inc.’s EPS estimate?
ViaDerma, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ViaDerma, Inc. have?
ViaDerma, Inc. has 1,233,713,100 shares outstanding.
What happened to ViaDerma, Inc.’s price movement after its last earnings report?
ViaDerma, Inc. reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of ViaDerma, Inc.?
Currently, no hedge funds are holding shares in VDRM
Company Description
ViaDerma, Inc.
ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California.
Technical Analysis
Aurinia Pharmaceuticals
―
Cidara Therapeutics
―
Aclaris Therapeutics
―
Purple Biotech
―
Journey Medical Corp
―